Another question(s) as an open IND gets closer and
Post# of 5066
Would the company be in the position to be in international studies after approval?
Would the company have strong intentions to run parallel studies with the INDs? I ask this as so many indications have been mentioned within each IND, and most recently, using these therapies all-together synergistically.